Get started
Author

S.A. Ahn

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
1992 · M A Konstam, M F Rousseau, et al. · Circulation · 602
PDF
Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
1993 · M A Konstam, M W Kronenberg, et al. · Circulation · 316
Effects of long-term enalapril therapy on left ventricular diastolic properties in patients with depressed ejection fraction. SOLVD Investigators.
1993 · H Pouleur, M F Rousseau, et al. · Circulation · 79
PDF
Circulating urotensin II levels in moderate to severe congestive heart failure: Its relations with myocardial function and well established neurohormonal markers
2005 · D. Gruson, M.F. Rousseau, et al. · Peptides · 58
Galectin-3 testing: Validity of a novel automated assay in heart failure patients with reduced ejection fraction
2013 · D. Gruson, M. Mancini, et al. · Clinica Chimica Acta · 29
Statin therapy and cataract in type 2 diabetes
2010 · M.P. Hermans, S.A. Ahn, et al. · Diabetes & Metabolism · 23
Circulating levels of stress associated peptide Urocortin in heart failure patients
2009 · D. Gruson, S.A. Ahn, et al. · Peptides · 17
What is the phenotype of patients with gastrointestinal intolerance to metformin?
2013 · M.P. Hermans, S.A. Ahn, et al. · Diabetes & Metabolism · 16
Measurement of Galectin-3 with the ARCHITECT assay: Clinical validity and cost-effectiveness in patients with heart failure
2014 · D. Gruson, M. Mancini, et al. · Clinical Biochemistry · 14
Do high ferritin levels confer lower cardiovascular risk in men with Type 2 diabetes?
2010 · M. P. Hermans, S. A. Ahn, et al. · Diabetic Medicine · 11
Comparison between intact and bioactive parathyroid hormone assays in patients with severe heart failure
2012 · D. Gruson, T. Lepoutre, et al. · Clinical Biochemistry · 10
Lipoprotein(a) levels are doubled in left-handed patients with diabetes
2018 · M.P. Hermans, S.A. Ahn, et al. · Diabetes & Metabolism · 5
Handedness, insulin sensitivity and pancreatic B‐cell function in Type 2 diabetes
2009 · M. P. Hermans, S. A. Ahn, et al. · Diabetic Medicine · 5
Beneficial Neuroendocrine Modulation of Spironolactone in Severe Congestive Heart Failure
2000 · M.F. Rousseau, W. Van Mieghem, et al. · European Journal of Heart Failure · 4
Les marqueurs hormonaux de la décompensation cardiaque
2000 · Philippe L. Selvais, Annie Robert, et al. · DIAL (Catholic University of Leuven) · 1
Groupes sanguins ABO et risque macrovasculaire dans le DT2
2024 · F.O. Lurquin, E.L. Petit, et al. · Annales d Endocrinologie
MSR48 Utilization of High-Dimensional Propensity Score and Targeted Maximum Likelihood Estimation with Machine Learning to Improve Causal Effect Estimation in Patients with Nonvalvular Atrial Fibrillation and Hypertension
2024 · D Zhang, Y Zhang, et al. · Value in Health
Elevated CA125 levels using ABEI-based assay in heart failure: Correlation with disease severity and cardiac biomarkers
2024 · D. Gruson, D. Maisin, et al. · Clinica Chimica Acta
231Global myocardial longitudinal strain by feature tracking cardiac magnetic resonance does not influence the prognosis of patients with heart failure with reduced ejection fraction
2019 · M S Amzulescu, L Houard, et al. · European Heart Journal - Cardiovascular Imaging
PDF
188Right ventricular 2-dimensional speckle tracking echocardiography is a better predictor of outcomes than MRI-derived RVEF in HF-rEF
2018 · L Houard, A C Pouleur, et al. · European Heart Journal
PO08 Dans quelle mesure la prévalence du diabète prédit les événements ischémiques: une méta-analyse de 212 850 patients de 29 grands essais cliniques
2015 · M.P. Hermans, S.A. Ahn, et al. · Diabetes & Metabolism
P022 Estimation du risque de cardiopathie ischémique en relation avec la dyslipidémie athérogène chez des patients diabétiques de type 2
2015 · M.P. Hermans, D. Amoussou Guenou, et al. · Diabetes & Metabolism
P182 Hypovitaminose D et dyslipidémie athérogène dans le diabète de type 2
2014 · M. Hermans, S. Camara, et al. · Diabetes & Metabolism
P2117 Phénotype cardiométabolique et fonction insulino-secrétoire de diabétiques de type 2 âgés et de patients âgés avec diabète de survenue tardive
2013 · M.P. Hermans, S.A. Ahn, et al. · Diabetes & Metabolism
P41 Protection paradoxale pour la maladie coronarienne de l’association d’histoires familiales de diabète et de maladie cardiovasculaire
2012 · M.P. Hermans, S.A. Ahn, et al. · Diabetes & Metabolism
Works count: 25
Citation count: 1,190
H-index: 10
I10-index: 11
Year
Topic
Type